This study to assess aesthetic improvement following treatment with QM1114-DP.
This is an open-label, single-center multi-center study to assess aesthetic improvement in the Glabellar and Lateral Canthal regions following treatment with QM1114-DP.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
25
QM1114-DP
Galderma Research Site
New York, New York, United States
Responders in QM1114-DP versus Placebo using the Global Aesthetic Improvement Scale (GAIS) at maximum frown at Month 1
Responder Rate is defined as a subject who responds at least Improved on the GAIS at maximum frown
Time frame: 1 month
Responders in QM1114-DP versus Placebo using the Global Aesthetic Improvement Scale (GAIS) at maximum smile at Month 1
Responder Rate is defined as a subject who responds at least Improved on the GAIS at maximum smile
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.